15 pharmaceutical companies were fined a maximum of 460,000 yuan.

On September 14, the Sichuan Provincial Drug Administration announced the disclosure of information on administrative penalties for the production and sale of inferior drugs by eight pharmaceutical companies.
The Guangdong Provincial Drug Administration has published information on administrative penalties for the production and sale of counterfeit and inferior drugs by six pharmaceutical companies.
The Jiangxi Provincial Drug Administration released information on administrative penalties for non-compliance with GMP.
▍1. Chengdu Yulong Chinese Medicine Drink Tablets Co., Ltd. production and sale of inferior medicine Sichuan Wu case parties to the production and sale of Chinese medicine beverage tablets Sichuan Wu (lot number: 190401-01) nature does not comply with the "Chinese Pharmacopeia" (2015 edition) a provision, should be punished according to the terms of inferior medicine, the value of 5050 yuan, illegal income 2013 yuan.
in accordance with article 74 of the Drug Administration Law (as amended in 2015) and Article 23 of the Administrative Punishment Law, the company was ordered to correct the illegal act and decided to give the following administrative penalties: 1. Confiscation of the illegal production of The production of The production of Sichuan Wu (lot number: 190401-01) 31.7 kg; 2, confiscation of illegal income 2013 yuan; 3, the value of the goods 1 times the fine of 5050 yuan.
more than 7,063 yuan.
▍ II, Sichuan Zhihe Xin Pharmaceutical Co., Ltd. sales of inferior drugs Lansolazole intestinal solution case parties to the production and sale of Lanso laazole intestinal solution tablets (lot number: 191103, marked production enterprises: Sichuan Chengdu Tongdotang Pharmaceutical Co., Ltd.) content determination does not meet the "China Pharmacopoeia" (2015 edition) a provision, should be inferior drugs.
illegal income of 396.93 yuan.
In accordance with article 117 of the Drug Administration Law (revised 2019), Article 75 of the Regulations on the Implementation of the Drug Administration Law and Article 23 of the Administrative Punishment Law, the company was ordered to correct the illegal act and decided to impose the following administrative penalties: confiscation of the illegal proceeds of 396.93 yuan.
▍ 3, Sichuan Chengdu Tongdotang Pharmaceutical Co., Ltd. production and sale of the inferior drug Lansorazole intestinal tablets case parties to the production and sale of lanso laazole intestinal tablets (lot number: 191103) content determination does not meet the "Chinese Pharmacopoeia" (2015 edition) a provision, should be inferior drugs.
value of the goods was 198,271 yuan, and the illegal income was 57,454.7 yuan.
In accordance with the provisions of Article 74 of the Drug Administration Act (amendment in 2015) and Article 23 of the Administrative Penalties Act, you are ordered to correct the illegal act and decide to give the following administrative penalties: 1. Confiscation of the illegally produced Lansorazole intestinal solution (lot number: 191103) 13424 boxes; 2. Confiscation of illegal income of 57454.7 yuan; 3. And a fine of 1 times the value of the goods 198271 yuan.
and above the total amount of 255,725.7 yuan.
▍ 4, Sichuan Jiuxing Pharmaceutical Co., Ltd. sales of inferior drugs Huang Jing case parties to the sale of Chinese medicine tablets Huang Jing (lot number: 180101, marked production enterprises: Chengdu Ji'ankang Pharmaceutical Co., Ltd.) nature does not comply with the "China Pharmacopoeia" (2015 edition) a provision, should be punished according to the bad medicine theory, illegal income of 210 yuan.
In accordance with article 117 of the Drug Administration Law (revised 2019), Article 75 of the Regulations on the Implementation of the Drug Administration Law and Article 23 of the Administrative Punishment Law, the company was ordered to correct the illegal act and decided to impose the following administrative penalties: confiscation of the illegal proceeds of 210 yuan.
Chengdu Ji'ankang Pharmaceutical Co., Ltd. production and sale of inferior drug yellow essence case parties to the production and sale of Chinese medicine tablets huang jing (lot number: 180101) nature does not comply with the "Chinese Pharmacopoeia" (2015 edition) a provision, should be punished according to the bad medicine theory, the value of the value of 61831 yuan, illegal income of 29411.09 yuan.
In accordance with article 74 of the Drug Administration Law (as amended in 2015) and Article 23 of the Administrative Punishment Law, the company was ordered to correct the illegal act and decided to give the following administrative penalties: 1. Confiscation of the illegal production of Chinese medicine tablets Huang Jing (lot number: 180101) 352.63 kg; 2. Confiscation of illegal income of 29411.09 yuan; 3. And a fine of 61831 yuan for 1 times the value of the goods.
and above totaled 91242.09 yuan.
▍ 5, Chengdu Ji'ankang Pharmaceutical Co., Ltd. production and sale of the case of the inferior drug Huang Jing parties to the production and sale of Chinese medicine tablets Huang Jing (lot number: 180101) does not comply with the "Chinese Pharmacopoeia" (2015 edition) a provision, should be punished according to the inferior medicine theory, the value of the value of 61831 yuan, illegal income of 29411.09 yuan.
In accordance with article 74 of the Drug Administration Law (as amended in 2015) and Article 23 of the Administrative Punishment Law, the company was ordered to correct the illegal act and decided to give the following administrative penalties: 1. Confiscation of the illegal production of Chinese medicine tablets Huang Jing (lot number: 180101) 352.63 kg; 2. Confiscation of illegal income of 29411.09 yuan; 3. And a fine of 61831 yuan for 1 times the value of the goods.
and above totaled 91242.09 yuan.
▍6. Sichuan Co▍. , Sichuan Co., Ltd. sales of inferior drugs injectable amica star, shiyu night light pill case parties sell injection amicca star sulfate (lot number: 1912044, production enterprises: Jiangsu Wu Chinese Medicine Group Co., Ltd. Suzhou Pharmaceutical Factory), Shi Night light pills (lot number: 191006, production enterprises: Jilin Province Tonghua Boxiang Pharmaceutical Co., Ltd.), by drug supervision and testing, the results do not meet the "Chinese Pharmacopoeia" 205 edition of the second inspection provisions, for inferior drugs, illegal income totalling 2008.45 yuan.
In accordance with article 117 of the Drug Administration Law (revised in 2019), Article 75 of the Regulations on the Implementation of the Drug Administration Law and Article 23 of the Administrative Punishment Law, the company was ordered to correct the illegal act and decided to impose the following administrative penalties: confiscation of the illegal proceeds of 2008.45 yuan.
▍, Sichuan Xinrentai Pharmaceutical Co., Ltd. production and sale of winter inferior drugs case parties to the production and sale of winter Chinese medicine tablets (lot number: 190301) nature does not conform to the "Chinese Pharmacopoeia" (2015 edition) a provision that should be recognized as the production and sale of inferior drugs, the value of the value of 27,996.16 yuan, illegal income of 27,760.50 yuan.
In accordance with the provisions of Article 74 of the Drug Administration Law, the parties concerned shall be ordered to make corrections to the production and sale of inferior drugs, and have decided to give the following administrative penalties: 1. Confiscation of illegal proceeds from the illegal production and sale of inferior drugs in winter and winter amounting to RMB27,760.50; 2, and the amount of illegal production of winter drugs doubled the value of the fine, amounting to 27,996.16 yuan;
▍ 8, Sichuan Yufengtang Pharmaceutical Co., Ltd. production of huang fine and inferior medicine case parties to the production of yellow fine Chinese medicine tablets (lot number: 190801) does not comply with the "Chinese Pharmacopoeia" (2015 edition) a provision, should be identified as the production of inferior drugs, the value of the value of 42,268.35 yuan, illegal income of 21216.31 yuan.
In accordance with the provisions of Article 74 of the Drug Administration Law (amendment in 2015), the parties concerned shall be ordered to make corrections to the production of jaundic and inferior drugs, and the following administrative penalties shall be decided: 1, confiscation of illegally produced yellow refined drugs 212.015 kg; 2, and the amount of illegal production of yellow fine drugs doubled the value of the fine, amounting to 42,268.35 yuan;
▍9, Shenzhen Minghuatang Pharmaceutical Co., Ltd. production of counterfeit medicine sand kernel case parties to the sale of Chinese medicine drinking tablets sand kernels (lot number: 18050101) "character" test results for "this product is non-sand kernel standards prescribed varieties, do not meet the provisions."
in accordance with Article 75 of the Regulations on the Implementation of the Drug Administration Law of the People's Republic of China.
Confiscation of illegal income, confiscation of illegal property 1.741105 (million yuan) ▍10, Huayi Chinese medicine tablets Co., Ltd., Huazhou City, Chinese medicine tablets factory production of inferior medicine Tiandong case parties produced Chinese medicine tablets winter (label manufacturer: Huayi Chinese medicine tablets Co., Ltd. Chinese medicine tablets factory, batch number: 190601, packaging specifications: 250 g / pack), by Foshan Shunde District Drug Inspection Institute test: "the nature" project test results for the winter (drink tablets) standard prescribed varieties, but drink tablets are not cut (not in accordance with the provisions) ", does not meet the "Chinese Pharmacopoeia" 2015 version of a standard provisions.
ordered to make corrections and issued a warning in accordance with Article 117 of the Drug Administration Law of the People's Republic of China (2019 edition).
▍11, Huayi Chinese medicine tablets Co., Ltd. Chinese medicine beverage tablets factory in Huazhou City, the production of inferior medicine Penang case parties to the production of Chinese medicine drink tablets Penang (label manufacturer: Huayi Chinese medicine tablets Co., Ltd. Chinese medicine tablets factory, batch number: 200101, packaging specifications: 250 g / pack), by Dongguan City Food and Drug Inspection Institute inspection: "check-moisture" project test results of 10.4%, does not meet the "Chinese Pharmacopoeia" 2015 version of a standard provisions.
ordered to make corrections and issued a warning in accordance with Article 117 of the Drug Administration Law of the People's Republic of China (2019 edition).
▍ 12, Guangzhou Kanghe Pharmaceutical Co., Ltd. production and sale of the inferior drug guavisin double-dimensional B tablets, the parties to the production and sale of the drug guavisin two-dimensional B tablets (lot number: 180502) after testing the uniformity of the content, content determination items do not meet the requirements In accordance with Article 74 of the Drug Administration Law of the People's Republic of China (2015 Amendment), the penalty is: Confiscation of illegal income from illegal production and sale, and a fine of 1.5 times the value of the illegal production and sale of drugs, with a fine of 28.051956 yuan (10,000 yuan) Confiscation of illegal income, confiscation of illegal property amount (10,000 yuan) 18.461224 Total fine of 465.1368 million yuan▍ The production and sale of pharmaceutical vehicle front grass (lot number: 171001) after testing content determination does not meet the provisions in accordance with the People's Republic of China Drug Administration Law (2015 Amendment) Article 74: 1, confiscation of illegal production, sale of illegal income, and illegal production, A fine of 0.1985 million yuan for selling drugs worth twice the amount;
total fine of 0.2957 million yuan.
▍ 14, Guangdong Dingkang Pharmaceutical Co., Ltd. production of counterfeit medicine guxitry draft party production of grain essence grass, batch number 170801, "nature" does not meet the requirements.
In accordance with Article 73 of the Drug Administration Law of the People's Republic of China (as amended in 2015) and Article 10 of the Regulations on the Application of the Discretionary Power to Regulate Administrative Punishment by the Food and Drug Administration of Guangdong Province: 1. Confiscation of illegal income: 918.00 yuan;
total fine of 4428.50 yuan.
▍, Jiangxi Province, Shanghai Gao County Oxygen Co., Ltd. did not comply with the GMP case parties did not comply with the drug production quality management norms.
100,000 yuan in accordance with Article 126 of the Drug Administration Law of the People's Republic of China.
.